EP1254269A4 - Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm) - Google Patents

Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)

Info

Publication number
EP1254269A4
EP1254269A4 EP01908837A EP01908837A EP1254269A4 EP 1254269 A4 EP1254269 A4 EP 1254269A4 EP 01908837 A EP01908837 A EP 01908837A EP 01908837 A EP01908837 A EP 01908837A EP 1254269 A4 EP1254269 A4 EP 1254269A4
Authority
EP
European Patent Office
Prior art keywords
type
ngm
neuronal
polynucleotides
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01908837A
Other languages
German (de)
English (en)
Other versions
EP1254269A1 (fr
Inventor
Bryan J Boyle
George Yeung
Matthew C Arterburn
Chenghua Liu
Y Tom Tang
Shubhada D Godbole
Chiaoyun Kuo
Radoje T Drmanac
Sereando Palencia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Priority to EP05005504A priority Critical patent/EP1574520A3/fr
Publication of EP1254269A1 publication Critical patent/EP1254269A1/fr
Publication of EP1254269A4 publication Critical patent/EP1254269A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP01908837A 2000-02-03 2001-02-02 Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm) Withdrawn EP1254269A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05005504A EP1574520A3 (fr) 2000-02-03 2001-02-02 Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US49691400A 2000-02-03 2000-02-03
US496914 2000-02-03
US56087500A 2000-04-27 2000-04-27
US560875 2000-04-27
US72111500A 2000-11-22 2000-11-22
US721115 2000-11-22
PCT/US2001/003661 WO2001057262A1 (fr) 2000-02-03 2001-02-02 Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)

Publications (2)

Publication Number Publication Date
EP1254269A1 EP1254269A1 (fr) 2002-11-06
EP1254269A4 true EP1254269A4 (fr) 2004-10-27

Family

ID=27414045

Family Applications (2)

Application Number Title Priority Date Filing Date
EP05005504A Withdrawn EP1574520A3 (fr) 2000-02-03 2001-02-02 Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés
EP01908837A Withdrawn EP1254269A4 (fr) 2000-02-03 2001-02-02 Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP05005504A Withdrawn EP1574520A3 (fr) 2000-02-03 2001-02-02 Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés

Country Status (4)

Country Link
EP (2) EP1574520A3 (fr)
AU (1) AU2001236663A1 (fr)
CA (1) CA2399652A1 (fr)
WO (1) WO2001057262A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064369A1 (en) * 2000-07-28 2003-04-03 Taupier Raymond J. Novel proteins and nucleic acids encoding same
US7223558B2 (en) 2001-07-11 2007-05-29 Bristol-Myers Squibb Company Polynucleotides encoding three novel human cell surface proteins with leucine rich repeats and immunologobulin folds, BGS2, 3, and 4 and variants thereof
CA2519227C (fr) 2003-03-19 2013-12-03 Biogen Idec Ma Inc. Proteine de liaison de recepteur de nogo
US8486893B2 (en) 2004-06-24 2013-07-16 Biogen Idec Ma Inc. Treatment of conditions involving demyelination
HRP20131066T1 (hr) 2005-07-08 2013-12-06 Biogen Idec Ma Inc. Sp35 antitijela i njihova upotreba
US8128926B2 (en) 2007-01-09 2012-03-06 Biogen Idec Ma Inc. Sp35 antibodies and uses thereof
CA2729961C (fr) 2008-07-09 2018-05-01 Biogen Idec Ma Inc. Anticorps anti-lingo, li113, li62 variant co2
KR102142161B1 (ko) 2012-05-14 2020-08-06 바이오젠 엠에이 인코포레이티드 운동 뉴런 관련 병태 치료용 lingo-2 길항제
JP2018504400A (ja) 2015-01-08 2018-02-15 バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． Ｌｉｎｇｏ‐１拮抗薬及び脱髄障害の治療のための使用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006427A1 (fr) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Molecules d'acide nucleique tango-78, tango-79 et tango-81
WO1999055865A1 (fr) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isoles de cellules de la peau et leurs procedes d'utilisation
WO2000071584A1 (fr) * 1999-05-20 2000-11-30 Human Genome Sciences, Inc. Genes recepteurs heptatransmembranaires
WO2001000638A2 (fr) * 1999-06-29 2001-01-04 Millennium Pharmaceuticals, Inc. Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5320700A (en) * 1999-06-04 2000-12-28 Millennium Pharmaceuticals, Inc. Novel toll molecules and uses therefor
US20030064369A1 (en) * 2000-07-28 2003-04-03 Taupier Raymond J. Novel proteins and nucleic acids encoding same
CA2421576A1 (fr) * 2000-09-15 2002-03-28 Curagen Corporation Nouveau polynucleotides et polypeptides codes par ces polynucleotides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999006427A1 (fr) * 1997-08-04 1999-02-11 Millennium Biotherapeutics, Inc. Molecules d'acide nucleique tango-78, tango-79 et tango-81
WO1999055865A1 (fr) * 1998-04-29 1999-11-04 Genesis Research And Development Corporation Limited Polynucleotides isoles de cellules de la peau et leurs procedes d'utilisation
WO2000071584A1 (fr) * 1999-05-20 2000-11-30 Human Genome Sciences, Inc. Genes recepteurs heptatransmembranaires
WO2001000638A2 (fr) * 1999-06-29 2001-01-04 Millennium Pharmaceuticals, Inc. Nouveaux genes codant des proteines pouvant etre utilisees dans des domaines diagnostiques, preventifs, therapeutiques ou autres

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO0157262A1 *
WANG KUAN HONG ET AL: "Biochemical purification of a mammalian Slit protein as a positive regulator of sensory axon elongation and branching", CELL, vol. 96, no. 6, 19 March 1999 (1999-03-19), pages 771 - 784, XP002273837, ISSN: 0092-8674 *

Also Published As

Publication number Publication date
EP1574520A3 (fr) 2005-12-21
WO2001057262A1 (fr) 2001-08-09
AU2001236663A1 (en) 2001-08-14
EP1254269A1 (fr) 2002-11-06
CA2399652A1 (fr) 2001-08-09
EP1574520A2 (fr) 2005-09-14

Similar Documents

Publication Publication Date Title
DE60112690D1 (de) Anordnung von Strömungsleitelementen
DE60112212D1 (de) Ein Agent zum integriertem Verfassen von Anmerkungen und Wiederauffinden von Bildern
EP1652221A4 (fr) Procedes et systemes d'analyse des defaillances
NO20031280D0 (no) Strömningskontrollapparatur for bruk i en brönn
DE60235684D1 (de) Probevolumen-Messapparat
ATE306318T1 (de) Entschwefelung und hierfür geeignetes sorbens
DE60110944D1 (de) Magnetoresistive Anordnung und diese verwendendes magnetisches Speicherelement
EP1514107A4 (fr) Procedes d'analyse proteomique quantitative de glycoproteines
DE69919639D1 (de) Elektrisch betriebene Klemmvorrichtrung zum Verstellen der Position eines Teiles bezüglich eines anderen Teiles
DE60136801D1 (de) Schreibgerät
EP1254269A4 (fr) Procedes et matieres lies aux polypeptides et aux polynucleotides du type molecule de guidage neuronal (du type ngm)
DE50002001D1 (de) Anordnung zum verhältnisgleichen Ausbringen von zwei fliessfähigen Substanzen, insbesondere für Dentalzwecke
DE69533119D1 (de) Spektroskopische Messvorrichtung zur Analyse von Medien
EP1642750A4 (fr) Instrument d'ecriture
DE10196363T1 (de) Tragbarer Kraftstoffanalysator zum Analysieren des Alkoholgehalts eines Mischkraftstoffs
DE50212826D1 (de) Variantenreduzierte Drosseleinrichtung mit austauschbaren Gehäuseteilen
EP1963840A4 (fr) Appareil et trousse d'immunoessai
NO20030977D0 (no) Avsvovling og nye sorbenter for samme
DE60111333D1 (de) Lenkung und Vorrichtung zum Berechnen der inneren Verluste für diese Lenkung
EP1757945A4 (fr) Appareil d"analyse
EP1546985A4 (fr) Analyse d'etat
DE60334850D1 (de) Lecksicheres schreibinstrument
DE59804890D1 (de) Vorrichtung zum analysieren gasförmiger proben
DE60139246D1 (de) Erwärmung eines probenträgers
DE60126295D1 (de) Säule zur Messung von longitudinalen Dimensionen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020827

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO INC.

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NUVELO, INC.

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/47 A

A4 Supplementary search report drawn up and despatched

Effective date: 20040913

17Q First examination report despatched

Effective date: 20050110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050503